3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Completed
3
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Conditions
Arthritis, Rheumatoid
13
Spondylitis, Ankylosing
5
Colitis, Ulcerative
4
Psoriasis
3
Crohn Disease
3
Uveal Melanoma
1
Thyroid Carcinoma, Anaplastic
1
Spondylarthritis
1
Sarcoidosis
1
Recurrence
1
Plaque Psoriasis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Melanoma
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammatory Bowel Diseases
1
Inflammation
1
Hidradenitis Suppurativa
1
Healthy Adult Male
1
Healthy
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Autoimmune Diseases
1
Interventions
tofacitinib
7
Etanercept
6
Methotrexate
3
Adalimumab
3
secukinumab
2
Nivolumab
2
sotrastaurin
1
sodium luminolate
1
ixekizumab
1
deucravacitinib
1
calcipotriene
1
cabozantinib
1
baricitinib
1
apremilast
1
abrocitinib
1
Vitamin D
1
Vaccines
1
Specimen Handling
1
Saline Solution
1
Platinum Compounds
1
Ipilimumab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Psoriasis
×
Adalimumab
×
Clear all
NCT02762955
2021-09-08
CALYPSO
Biocad
Phase 3
Completed
344 enrolled
NCT02196701
2018-03-19
CLEAR
AbbVie
Phase 3
Completed
46 enrolled
27 charts
NCT00932113
2017-08-31
MOA
Tufts Medical Center
Phase 4
Completed
33 enrolled
11 charts